Organization
Ludwig-Maximilians University of Munich
12 clinical trials
Clinical trial
Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)Status: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Phase 2 Study Evaluating the Safety, Tolerability and Efficacy of Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab in Patients With Treatment-Resistant Mixed Chimerism or Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia After Allogeneic Stem Cell TransplantationStatus: Withdrawn, Estimated PCD: 2021-05-31
Clinical trial
A Randomised Study to Assess the Efficacy of Cetuximab Rechallenge in Patients With Metastatic Colorectal Cancer (RAS Wild-type) Responding to First-line Treatment With FOLFIRI Plus CetuximabStatus: Active (not recruiting), Estimated PCD: 2023-11-01
Clinical trial
Avelumab Added to FOLFIRI Plus Cetuximab Followed by Avelumab Maintenance in Patients With Previously Untreated RAS Wild-type Colorectal Cancer. The Phase II FIRE-6 StudyStatus: Active (not recruiting), Estimated PCD: 2023-11-01
Clinical trial
Randomised Study to Investigate FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab as First-line Treatment of BRAF-mutated Metastatic Colorectal CancerStatus: Active (not recruiting), Estimated PCD: 2023-11-01
Clinical trial
A Double-Blind Crossover Within Subject Study on Low-Dose Hydrocortisone for FibromyalgiaStatus: Completed, Estimated PCD: 2007-05-01
Clinical trial
Pharmacokinetic Profile of Betahistine Serum Concentration With and Without Selegiline in Healthy Volunteers - a Prospective Mono-center Open-labeled Phase I Trial ("PK-BeST")Status: Completed, Estimated PCD: 2021-10-14
Clinical trial
Escalated Single Platelet Inhibition for One Month Plus Direct Oral Anticoagulation in Patients With Atrial Fibrillation and acUte coRonary Syndrome Undergoing percutaneoUS Coronary InterventionStatus: Recruiting, Estimated PCD: 2024-12-16
Clinical trial
A Randomized, 2-arm Non-comparative Phase II Study on the Efficacy of Atezolizumab and Roche Bevacizumab (Atezo/Bev) Followed by On-demand Selective TACE (sdTACE) Upon Detection of Disease Progression or of Initial Synchronous Treatment With TACE and Atezo/Bev on 24-months Survival Rate in the Treatment of Unresectable Hepatocellular Carcinoma PatientsStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor BurdenStatus: Active (not recruiting), Estimated PCD: 2023-09-16
Clinical trial
EffecTs of Amlodipine and Other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel DiseasesStatus: Terminated, Estimated PCD: 2022-07-28
Clinical trial
Trabectedin Combined With Regional Hyperthermia as Second Line Treatment for Adult Patients With Advanced Soft-tissue SarcomaStatus: Active (not recruiting), Estimated PCD: 2023-08-01